Showing 2981-2990 of 6035 results for "".
- Eyenovia and Arctic Vision Announce License Agreement to Develop and Commercialize Products in Greater China and South Koreahttps://modernod.com/news/eyenovia-and-arctic-vision-announce-license-agreement-to-develop-and-commercialize-products-in-greater-china-and-south-korea/2478143/Eyenovia and Arctic Vision announced that they have entered into an exclusive license agreement for Arctic Vision to develop and commercialize MicroPine for the treatment of progressive myopia and MicroLine for the treatment of presbyopia in Greater China (mainland China, Hong Kong, Macau and Tai
- At Least 97,000 Children Tested Positive For Coronavirus In Last 2 Weeks Of Julyhttps://modernod.com/news/at-least-97000-children-tested-positive-for-coronavirus-in-last-2-weeks-of-july-at-least-97000-children-tested-positive-for-the-coronavirus-during-the-last-two-weeks-of-july-according-to-a-new-revi/2478145/At least 97,000 children tested positive for the coronavirus during the last two weeks of July, according to a new review of state-level data by the Americ
- AstraZeneca Takes COVID-19 Vaccine to China With BioKangtai Deal for 200M-Dose Capacity by 2021https://modernod.com/news/astrazeneca-takes-covid-19-vaccine-to-china-with-biokangtai-deal-for-200m-dose-capacity-by-2021/2478134/Last week China was a notable missing element in AstraZeneca’s COVID-19 vaccine strategy, despite being the drugmaker’s second-largest market. That has changed, according to a FiercePharma
- Bausch + Lomb Launches -2.75 Cylinder for Biotrue ONEday for Astigmatism Daily Disposable Contact Lenseshttps://modernod.com/news/bausch-lomb-launches-2-75-cylinder-for-biotrue-oneday-for-astigmatism-daily-disposable-contact-lenses/2478129/Bausch + Lomb announced the US launch of the -2.75 cylinder parameter offering for Biotrue ONEday for Astigmatism daily disposable contact lenses, the first and only toric daily disposable with a -2.75 cylinder. This new parameter offering will be available for same day fitting in a standard fit
- EyePoint Pharmaceuticals and ImprimisRx Announce U.S. Commercial Alliance for Dexycuhttps://modernod.com/news/eyepoint-pharmaceuticals-and-imprimisrx-announce-u-s-commercial-alliance-for-dexycu/2478119/EyePoint Pharmaceuticals and ImprimisRx announced the signing of a commercial alliance for the joint promotion of Dexycu (dexamethasone intraocular suspension) 9% for the treatment of postoperative inflammation following ocular surgery in the United States.
- Sanofi, GSK Gain $2.1 Billion From US Government for Development, Supply of COVID-19 Vaccinehttps://modernod.com/news/sanofi-gsk-gain-2-1-billion-from-us-government-for-development-supply-of-covid-19-vaccine/2478107/Sanofi and GlaxoSmithKline announced that the US government will provide more than $2.1 billion to support further development, manufacturing and delivery of initial doses of the companies’ adjuvanted vaccine against COVID-19. The vaccine candidate is based on Sanofi’s recombinant pro
- Kubota Vision Demonstrates 3D Imaging Capabilities Using AI on PBOShttps://modernod.com/news/kubota-vision-demonstrates-3d-imaging-capabilities-using-ai-on-pbos/2478095/Kubota Vision announced that the company demonstrated 3D imaging capabilities using artificial intelligence (AI) on its Patient Based Ophthalmology Suite (PBOS) in-home optical coherence tomography (OCT) device.1 Kubota Vision completed a successful clinical study in October 201
- OCT Angiography a Good Way to Detect Diabetic Retinopathyhttps://modernod.com/news/oct-angiography-a-good-way-to-detect-diabetic-retinopathy/2478091/Wide-field swept-source optical coherence tomography angiography (WF OCTA) can detect diabetic retinopathy as well as fluorescein angiography and ultrawide-field color fundus photography, according to results from two analyses, as report i
- Senate GOP Outlines Next Coronavirus Relief Bill as Deadline for Enhanced Unemployment Benefits Nearshttps://modernod.com/news/senate-gop-outlines-next-coronavirus-relief-bill-as-deadline-for-enhanced-unemployment-benefits-nears/2478090/Senate Republicans outlined their fourth phase of federal coronavirus response efforts, rolling out their legislative package as enhanced unemployment benefits are beginning to expire for millions of Americans who are out of work due to the coronavirus pandemic, accordin
- Ocugen Granted FDA Orphan Drug Designation for Gene Therapy for the Treatment of RHO Mutation-Associated Retinal Degenerative Diseasehttps://modernod.com/news/ocugen-granted-fda-orphan-drug-designation-for-gene-therapy-for-the-treatment-of-rho-mutation-associated-retinal-degenerative-disease/2478081/Ocugen announced the FDA granted the third orphan drug designation (ODD) for OCU400 in the treatment of RHO mutation-associated retinal degeneration. The RHO mutation is part of the retinitis pigmentosa (RP) group of rare, genetic disorders that involve a breakdown and loss of